Drug Trial Radar · NCT07396441
Supplementary Kelulut Honey Therapy in Juvenile Open-Angle Glaucoma: Effects on IL-6, RNFL and Dry Eye
Last checked: Nov 20, 2026Latest source record: Feb 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Jan 15, 2026
Primary completion
May 15, 2026
Study completion Jun 30, 2026
Sponsor
- Lead sponsor
- Universiti Sains MalaysiaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Hospital Raja Perempuan Zainab II, Kota Bahru, Kelantan; Hospital Sultanah Nur Zahirah, Kuala Terengganu; Hospital Universiti Sains Malaysia
- First posted
- Feb 9, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 15 years, up to 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to evaluate the effects of stingless bee honey (Kelulut honey) in juvenile open-angle glaucoma patients. The study evaluates the effects on serum Interleukin 6 level(IL-6), retinal nerve fiber layer(RNFL) thickness and dry eye-related symptoms. A total of 60 participants who meet the study criteria will be randomly assigned to one of two groups. One group will consume 30 grams of Kelulut honey daily for a period of three months, while the control group will not receive honey or a placebo. Serum IL-6 level, RNFL thickness, Tear break up time (TBUT) and Schirmer Test 1 will be done before and after 90 days. Adherence to honey consumption will be monitored using a daily diary. This study aims to provide better understanding of the potential role of Kelulut honey as a supplementary therapy in patients with juvenile open-angle glaucoma.
Conditions
- Juvenile Open Angle Glaucoma
- Dry Eye Disease (DED)
- Interleukin 6
- Retinal Nerve Fiber Layer Thickness
- HbA1c Level
Interventions
Stingless bee honey (Kelulut)Biological
Kelulut is stingless bee honey, a natural biologic product produced by stinglee bee species.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in the level of serum Interleukin-6 level before and after consumption of stingless bee honey for 3 months among patients with juvenile open angle glaucomaTime frame: from the enrolment to the end of study at 90 days
- serum Interleukin 6 levelTime frame: 90 days
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Hospital Raja Perempuan Zainab II
Kota Bharu, Kelantan, Malaysia · Recruiting
Hospital Sultan Ismail Petra
Kuala Krai, Kelantan, Malaysia · Recruiting
Hospital Universiti Sains Malaysia
Kubang Kerian, Kelantan, Malaysia · Recruiting
Hospital Sultanah Nur Zahirah
Kuala Terengganu, Terengganu, Malaysia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.